BALCHEM CORP Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2011 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Balchem Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2011 to Q1 2024.
- Balchem Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$302K, a 48.8% decline year-over-year.
- Balchem Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$10.8M, a 29.3% decline from 2022.
- Balchem Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$8.36M, a 40.7% decline from 2021.
- Balchem Corp annual Deferred Income Tax Expense (Benefit) for 2021 was -$5.94M, a 28.5% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)